Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation by Groenendijk, Floris H., Mellema, Wouter W., van der Burg, Eline, Schut, Eva, Hauptmann, Michael, Horlings, Hugo M., Willems, Stefan M., van den Heuvel, Michel M., Jonkers, Jos, Smit, Egbert F., Bernards, René

Get full text

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non―Small Cell Lung Cancer with a KRAS Mutation by DINGEMANS, Anne-Marie C, MELLEMA, Wouter W, GROEN, Harry J. M, WIJK, Atie Van, BURGERS, Sjaak A, KUNST, Peter W. A, THUNNISSEN, Erik, HEIDEMAN, Danielle A. M, SMIT, Egbert F

Get full text

Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy by Mellema, Wouter W, van der Hoek, Dorien, Postmus, Pieter E, Smit, Egbert F

Get full text

Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report by Mellema, Wouter W, Burgers, Sjaak A, Smit, Egbert. F

Get full text

KRAS Mutations in Advanced Nonsquamous Non–Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value by Mellema, Wouter W., Dingemans, Anne-Marie C., Thunnissen, Erik, Snijders, Peter J.F., Derks, Jules, Heideman, Daniëlle A.M., Van Suylen, Robertjan, Smit, Egbert F.

Get full text

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer by Mellema, Wouter W, Masen-Poos, Lucie, Smit, Egbert F, Hendriks, Lizza E.L, Aerts, Joachim G, Termeer, Arien, Goosens, Martijn J, Smit, Hans J.M, van den Heuvel, Michel M, van der Wekken, Anthonie J, Herder, Gerarda J.M, Krouwels, Frans H, Stigt, Jos A, van den Borne, Ben E.E.M, Haitjema, Tjeerd J, Staal-Van den Brekel, Agnes J, van Heemst, Robbert C, Pouw, Ellen, Dingemans, Anne-Marie C

Get full text

Difference in Outcome between Types of KRAS Mutation May Point toward Difference in Tumor Biology by Mellema, Wouter W., Dingemans, Anne-Marie C., Jonker, Marianne, Smit, Egbert F.

Get full text

Abstract PR5: A phase II study of sorafenib in patients with stage IV non-small cell lung cancer (NSCLC) with a K-Ras mutation by Mellema, Wouter W., Dingemans, Anne-Marie C., Groen, Harry J.M., van Wijk, Atie, Burgers, Sjaak, Kunst, Peter W.A., Thunnissen, Frederik B., Heideman, Daniëlle A.M., Smit, Egbert F.

Get full text

Abstract 3635: A retrospective evaluation of metformin usage in patients with small cell lung cancer (SCLC) by Mellema, Wouter W., Aarts, Mieke J., Van Herk-Sukel, Myrthe P.P., Smit, Egbert F.

Get full text

Abstract A31: Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy by Mellema, Wouter W., Dingemans, Anne-Marie C., Smit, Egbert F., Derks, Jules, Heideman, Daniëlle A.M., van Suylen, Robertjan, Thunnissen, Frederik B.

Get full text

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer by van der Mijn, Johannes C., Sol, Nik, Mellema, Wouter, Jimenez, Connie R., Piersma, Sander R., Dekker, Henk, Schutte, Lisette M., Smit, Egbert F., Broxterman, Henk J., Skog, Johan, Tannous, Bakhos A., Wurdinger, Thomas, Verheul, Henk M. W.

Get full text

Online Studies on Variation in Orthopedic Surgery: Computed Tomography in MPEG4 Versus DICOM Format by Mellema, Jos J., Mallee, Wouter H., Guitton, Thierry G., van Dijk, C. Niek, Ring, David, Doornberg, Job N.

Get full text